Implantable Eye Telescope Receives FDA Approval

The U.S. Food and Drug Administration (FDA) approved the Implantable Miniature Telescope for treating patients with end-stage age-related macular degeneration (AMD). This visual prosthetic device is the first of its kind and will aid those patients with the most advanced form of AMD which is the leading cause of blindness in America's senior citizens. This revolutionary telescope implant is designed to improve the visual acuity of the patient. End-stage AMD causes the patient to suffer severe to profound central vision loss in both eyes. The Implantable Miniature Telescope reduces the impact of the blind spot caused by end-stage AMD. Created by Dr. Isaac Lipshitz, the Implantable Miniature Telescope is smaller than a pea and is implanted in one eye. The telescope delivers enlarged central vision images over a large area of the retina to enhance central vision. Peripheral vision is provided by the non-operated eye. The approval of this device adds a new treatment option for those suffering from the devastating effects of end-stage AMD.* Andrea Schumann Staff Writer